logo

For the Inventor, By the Inventor

Rungsted Kyst, Denmark

Christian Krog-Jensen

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignee: H. Lundbeck A/s. Active years: 2003-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Krog-Jensen. Retrieved from https://idiyas.com/inventor/christian-krog-jensen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • København, DK (2003)
  • Copenhagen, DK (2004)
  • Rungsted Kyst, DK (2005 - 2008)

Company Filing History:

goldMedal5 out of 513 
 
H. Lundbeck A/s
 patents

Years Active: 2003-2008

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 7393845 - Heteroaryl derivates, their preparation and use (2008-07-01),
2. 7342015 - Indole derivatives (2008-03-11),
3. 6921774 - Compounds and their use as glycine transport inhibitors (2005-07-26),
4. 6699864 - Substituted phenyl-piperazine derivatives, their preparation and use (2004-03-02),
5. 6596722 - Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use (2003-07-22),

Title: Christian Krog-Jensen: Innovator in Affective and Neurological Disorders

Introduction

Christian Krog-Jensen is a notable inventor based in Rungsted Kyst, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of affective and neurological disorders. With a total of 5 patents to his name, Krog-Jensen's work is recognized for its potential impact on mental health therapies.

Latest Patents

Among his latest patents, Krog-Jensen has developed compounds such as "Heteroaryl derivatives, their preparation and use." This invention focuses on a heteroaryl derivative that is useful for treating various affective disorders, including general anxiety disorder, panic disorder, obsessive-compulsive disorder, depression, social phobia, and eating disorders. Additionally, he has worked on "Indole derivatives," which also target similar affective and neurological disorders, including psychosis.

Career Highlights

Christian Krog-Jensen is currently employed at H. Lundbeck A/S, a company renowned for its dedication to improving the lives of people with brain diseases. His innovative work in drug development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Krog-Jensen collaborates with esteemed colleagues such as Ejner Knud Moltzen and Thomas Ruhland, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christian Krog-Jensen's contributions to the field of pharmaceuticals, particularly in the treatment of mental health disorders, highlight his role as a significant inventor. His ongoing work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…